0 CHECKOUT

Iron Deficiency Anemia - Pipeline Review, H2 2015

  • ID: 3384929
  • July 2015
  • 62 pages
  • Global Markets Direct
1 of 4

FEATURED COMPANIES

  • Panion & Bf Biotech Inc
  • Rockwell Medical, Inc.
  • Vifor Pharma AG
  • MORE

Iron Deficiency Anemia - Pipeline Review, H2 2015

Summary

The report ‘Iron Deficiency Anemia - Pipeline Review, H2 2015’, provides an overview of the Iron Deficiency Anemia’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Iron Deficiency Anemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Iron Deficiency Anemia and special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updation following a stringent READ MORE >

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Panion & Bf Biotech Inc
  • Rockwell Medical, Inc.
  • Vifor Pharma AG
  • MORE

List of Tables
List of Figures
Introduction
REPORT COVERAGE
Iron Deficiency Anemia Overview
Therapeutics Development
Pipeline Products for Iron Deficiency Anemia - Overview
Pipeline Products for Iron Deficiency Anemia - Comparative Analysis
Iron Deficiency Anemia - Therapeutics under Development by Companies
Iron Deficiency Anemia - Therapeutics under Investigation by Universities/Institutes
Iron Deficiency Anemia - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Iron Deficiency Anemia - Products under Development by Companies
Iron Deficiency Anemia - Products under Investigation by Universities/Institutes
Iron Deficiency Anemia - Companies Involved in Therapeutics Development
Panion & Bf Biotech Inc
Rockwell Medical, Inc.
Vifor Pharma AG
Iron Deficiency Anemia - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
ferric carboxymaltose - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ferric citrate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ferric maltol - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ferric pyrophosphate citrate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NSC-8679 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Proteins to Activate Erythroferrone for Iron Deficiency Anemia - Drug Profile
Product Description
Mechanism of Action
R&D Progress
VIT-91 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Iron Deficiency Anemia - Recent Pipeline Updates
Iron Deficiency Anemia - Dormant Projects
Iron Deficiency Anemia - Product Development Milestones
Featured News & Press Releases
May 12, 2015: Rockwell Medical Announces Triferic Clinical Data Selected for Four Presentations at the 52nd ERA-EDTA Congress May 28-31, 2015 in London, UK
May 05, 2015: Rockwell Medical to Present at Bank of America Merrill Lynch 2015 Health Care Conference
Mar 26, 2015: Rockwell Medical Announces Triferic Clinical Data Selected for Four Poster Presentations at National Kidney Foundation Spring Clinical Meetings March 26-29, 2015 in Dallas, Texas
Jan 26, 2015: U.S. FDA Approves Rockwell's Triferic for Iron Replacement and Maintenance of Hemoglobin in Hemodialysis Patients
Jan 09, 2015: Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch
Jan 09, 2015: Shield Therapeutics announces the publication of the AEGIS Feraccru Phase 3 pivotal trial manuscript in the Inflammatory Bowel Disease Journal
Jan 07, 2015: Rockwell Medical Announces Two Triferic Abstracts to be Presented at Annual Dialysis Conference Jan. 31 - Feb. 3, 2015 in New Orleans, Louisiana
Dec 15, 2014: American Regent's Injectafer (ferric carboxymaltose injection) Assigned J Code by Centers for Medicare & Medicaid Services
Dec 08, 2014: American Regent Announces Clinical Data Presentations at ASH 2014
Nov 11, 2014: Three clinical Presentations Highlight Novel Iron Replacement Drug Triferic at ASN
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Iron Deficiency Anemia, H2 2015
Number of Products under Development for Iron Deficiency Anemia - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Investigation by Universities/Institutes, H2 2015
Iron Deficiency Anemia - Pipeline by Panion & Bf Biotech Inc, H2 2015
Iron Deficiency Anemia - Pipeline by Rockwell Medical, Inc., H2 2015
Iron Deficiency Anemia - Pipeline by Vifor Pharma AG, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Iron Deficiency Anemia Therapeutics - Recent Pipeline Updates, H2 2015
Iron Deficiency Anemia - Dormant Projects, H2 2015

List of Figures
Number of Products under Development for Iron Deficiency Anemia, H2 2015
Number of Products under Development for Iron Deficiency Anemia - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Top 10 Targets, H2 2015
Number of Products by Stage and Top 10 Targets, H2 2015
Number of Products by Top 10 Mechanism of Actions, H2 2015
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015
Number of Products by Top 10 Routes of Administration, H2 2015
Number of Products by Stage and Top 10 Routes of Administration, H2 2015
Number of Products by Top 10 Molecule Types, H2 2015
Number of Products by Stage and Top 10 Molecule Types, H2 2015

Note: Product cover images may vary from those shown
3 of 4

Panion & Bf Biotech Inc
Rockwell Medical, Inc.
Vifor Pharma AG

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.